Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 05

1606P - Sarcopenia, depression, and modes of feeding among cancer patients

Date

21 Oct 2023

Session

Poster session 05

Topics

End-of-Life Care

Tumour Site

Presenters

Muhammad Khokhar

Citation

Annals of Oncology (2023) 34 (suppl_2): S887-S894. 10.1016/S0923-7534(23)01267-X

Authors

M.A. Khokhar1, S. Yaqub2, G. Abid3, I. Asif1, M. Farrukh Dar1, M. Naveed Sheikh2, G. Naseem2

Author affiliations

  • 1 Department Of Medical Oncology And Radiotherapy, King Edward Medical University, 54000 - Lahore/PK
  • 2 Medical Oncology & Radiotherapy Dept., King Edward Medical University, 54000 - Lahore/PK
  • 3 Biostatistics, Kinnaird College for Women, Lahore/PK

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1606P

Background

Sarcopenia refers to the loss of muscle mass and strength that occurs with aging and due to some medical conditions like cancer. Depression and inability to eat without assistance are common effects documented in cancer patients with sarcopenia. As a result, the goal of this study was to look into the relationship between sarcopenia, depression, and modes of feeding.

Methods

During the period beginning in January 2023 and ending in April 2023, cancer patients participated in a retrospective study. There has been a total of 150 participants enrolled in the trial, all of whom have been diagnosed with cancer. These people were enrolled in Mayo Hospital's Palliative Care Cancer Department in order to receive treatment. The Patient Health Questionnaire (PHQ-9) was used to determine the presence of depressive symptoms. The SARC-F was utilized to assess sarcopenia across all five dimensions. A self-report measure was utilized to assess modes of feeding [options include: 1) unable to eat without assistance 2) (self-fed with some difficulty, and 3) self-fed without any problem]. Sarcopenia, major depressive disorder, and feeding modes were studied using correlation analysis.

Results

We have observed a significant and negative association between modes of feeding and depression (r=-0.459, p<0.01), SARC1=Strength (r = -0.326, p<0.01), SARC2=Assistance in walking (r = -0.196, p<0.05), and SARC3=Rise from a chair (r = -0.238, p<0.01). These findings show that cancer patients are unable to eat without assistance when they suffer from sarcopenia which ultimately leads to more depressive symptoms.

Conclusions

Sarcopenia has a negative impact on the quality of life of patients, leading to depression and dependence on daily activities like self-eating which further complicates management.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.